GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (LSE:RENE) » Definitions » Price-to-Free-Cash-Flow

ReNeuron Group (LSE:RENE) Price-to-Free-Cash-Flow : N/A (As of May. 15, 2024)


View and export this data going back to 2005. Start your Free Trial

What is ReNeuron Group Price-to-Free-Cash-Flow?

As of today (2024-05-15), ReNeuron Group's share price is £0.03375. ReNeuron Group's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.09. Hence, ReNeuron Group's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for ReNeuron Group's Price-to-Free-Cash-Flow or its related term are showing as below:

LSE:RENE's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 32.39
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

ReNeuron Group's Free Cash Flow per Share for the six months ended in Sep. 2023 was £-0.04. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was £-0.09.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 33.20% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 25.50% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 14.10% per year.

During the past 13 years, ReNeuron Group's highest 3-Year average Free Cash Flow per Share Growth Rate was 46.40% per year. The lowest was -20.10% per year. And the median was 18.30% per year.


ReNeuron Group Price-to-Free-Cash-Flow Historical Data

The historical data trend for ReNeuron Group's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReNeuron Group Price-to-Free-Cash-Flow Chart

ReNeuron Group Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ReNeuron Group Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of ReNeuron Group's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, ReNeuron Group's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ReNeuron Group's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ReNeuron Group's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where ReNeuron Group's Price-to-Free-Cash-Flow falls into.



ReNeuron Group Price-to-Free-Cash-Flow Calculation

ReNeuron Group's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.03375/-0.093
=N/A

ReNeuron Group's Share Price of today is £0.03375.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. ReNeuron Group's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.09.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

ReNeuron Group  (LSE:RENE) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


ReNeuron Group Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of ReNeuron Group's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


ReNeuron Group (LSE:RENE) Business Description

Traded in Other Exchanges
Address
Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY
ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.